Literature DB >> 8258349

Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice.

J Katz1, C Benoist, D Mathis.   

Abstract

An early step in the development of autoimmune diabetes is lymphocyte infiltration into the islets of Langerhans of the pancreas, or insulitis. The infiltrate contains both CD4+ and CD8+ T cells and both are required for progression to diabetes in non-obese diabetic (NOD) mice. It has been thought that the CD4+ lymphocytes are the initiators of the disease, the islet invaders, while CD8+ cells are the effectors, the islet destroyers. We question this interpretation because NOD mice lacking MHC class I molecules, hence CD8+ T cells, do not display even insulitis when expected.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8258349     DOI: 10.1002/eji.1830231244

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  61 in total

Review 1.  Effector lymphocytes in islet cell autoimmunity.

Authors:  Pere Santamaria
Journal:  Rev Endocr Metab Disord       Date:  2003-09       Impact factor: 6.514

2.  Cutting edge: merocytic dendritic cells break T cell tolerance to beta cell antigens in nonobese diabetic mouse diabetes.

Authors:  Jonathan D Katz; Jennifer K Ondr; Robert J Opoka; Zacharias Garcia; Edith M Janssen
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

3.  Low incidence of autoimmune type I diabetes in BB rats fed a hydrolysed casein-based diet associated with early inhibition of non-macrophage-dependent hyperexpression of MHC class I molecules on beta cells.

Authors:  X B Li; F W Scott; Y H Park; J W Yoon
Journal:  Diabetologia       Date:  1995-10       Impact factor: 10.122

4.  Depletion of IL-2 receptor β-positive cells protects from diabetes in non-obese diabetic mice.

Authors:  Hanna Brauner; Håkan T Hall; Malin Flodström-Tullberg; Klas Kärre; Petter Höglund; Sofia Johansson
Journal:  Immunol Cell Biol       Date:  2015-08-05       Impact factor: 5.126

Review 5.  Targeting T lymphocytes for immune monitoring and intervention in autoimmune diabetes.

Authors:  Roberto Mallone; Gerald T Nepom
Journal:  Am J Ther       Date:  2005 Nov-Dec       Impact factor: 2.688

6.  Selective deletion of antigen-specific CD8+ T cells by MHC class I tetramers coupled to the type I ribosome-inactivating protein saporin.

Authors:  Paul R Hess; Carie Barnes; Matthew D Woolard; Michael D L Johnson; John M Cullen; Edward J Collins; Jeffrey A Frelinger
Journal:  Blood       Date:  2006-12-19       Impact factor: 22.113

7.  In CD4+ T-cell-induced diabetes, macrophages are the final effector cells that mediate islet beta-cell killing: studies from an acute model.

Authors:  Boris Calderon; Anish Suri; Emil R Unanue
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

8.  Beta cells cannot directly prime diabetogenic CD8 T cells in nonobese diabetic mice.

Authors:  James de Jersey; Sarah L Snelgrove; Stephanie E Palmer; Simon A Teteris; Arno Mullbacher; Jacques F A P Miller; Robyn M Slattery
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-17       Impact factor: 11.205

9.  Perforin-independent beta-cell destruction by diabetogenic CD8(+) T lymphocytes in transgenic nonobese diabetic mice.

Authors:  A Amrani; J Verdaguer; B Anderson; T Utsugi; S Bou; P Santamaria
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

10.  Ins2 deficiency augments spontaneous HLA-A*0201-restricted T cell responses to insulin.

Authors:  Irene Jarchum; Teresa P DiLorenzo
Journal:  J Immunol       Date:  2009-12-04       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.